In a mouse model of endotoxemia, mice treated with PPAR-α agonists before in vivo LPS challenge had 5 times higher plasma TNF-α levels than vehicle-treated animals.31 The relevance of these mouse and cell data to fibrate actions in humans in vivo remains unclear. The gene discussed is TNF; the disease is serum lipopolysaccharide activity.